UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Grimes & Company Inc.

Grimes & Company Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 22,823 shares of the healthcare conglomerate’s stock after purchasing an additional 234 shares during the quarter. Grimes & Company Inc.’s holdings in UnitedHealth Group were worth $11,545,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Linden Thomas Advisory Services LLC increased its position in shares of UnitedHealth Group by 13.7% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 4,297 shares of the healthcare conglomerate’s stock worth $2,174,000 after acquiring an additional 518 shares during the last quarter. Cyndeo Wealth Partners LLC increased its holdings in UnitedHealth Group by 4.4% during the 4th quarter. Cyndeo Wealth Partners LLC now owns 30,115 shares of the healthcare conglomerate’s stock worth $15,234,000 after purchasing an additional 1,273 shares during the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $6,922,000. Fifth Third Bancorp raised its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Fifth Third Bancorp now owns 476,285 shares of the healthcare conglomerate’s stock valued at $240,934,000 after acquiring an additional 1,907 shares in the last quarter. Finally, Chemung Canal Trust Co. increased its position in shares of UnitedHealth Group by 78.9% in the 4th quarter. Chemung Canal Trust Co. now owns 9,266 shares of the healthcare conglomerate’s stock worth $4,687,000 after purchasing an additional 4,086 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UNH opened at $532.26 on Friday. The stock has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm’s 50 day moving average is $541.04 and its 200-day moving average is $563.84.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. UnitedHealth Group’s payout ratio is currently 54.19%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.